Byrne, R. A., Colleran, R., Coughlan, J. J., Jauhar, R., Maillard, L., De Labriolle, A., Maeng, M., Croft, C., Brunner, M., Leistner, D., Zrenner, B., Kollum, M., Laugwitz, K.-L., Xhepa, E., Mayer, K., Lahu, S., Joner, M., Kirtane, A., … Mehran, R. (2024). Randomized Trial of COBRA PzF Stenting to Reduce the Duration of Triple Therapy: The COBRA-REDUCE Trial. Circulation: Cardiovascular Interventions, 17(10). https://doi.org/10.1161/circinterventions.123.013735

Ghannam, M., Al-Qudah, A. M., Alshaer, Q. N., Kronmal, R., Ntaios, G., Childs, C. A., Longstreth, W. T., Alsawareah, A., Keller, T., Serna-Higuita, L. M., Geisler, T., Furie, K., Saver, J. L., Kasner, S. E., Elkind, M. S. V., Tirschwell, D., Poli, S., Kamel, H., & Yaghi, S. (2024). Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source. Neurology, 103(9). https://doi.org/10.1212/wnl.0000000000209949

Anandalwar, S. P., O’Meara, L., Vesselinov, R., Zhang, A., Baum, J. N., Cooper, A., Decker, C., Schroeppel, T., Cai, J., Cullinane, D., Catalano, R. D., Bugaev, N., LeClair, M., Feather, C., McBride, K., Sams, V., Leung, P. S., Olafson, S., Callahan, D. S., … Ghneim, M. (2024). Warfarin, not direct oral anticoagulants or antiplatelet therapy, is associated with increased bleeding risk in emergency general surgery patients: Implications in this new era of novel anticoagulants: An EAST multicenter study. Journal of Trauma and Acute Care Surgery, 97(2), 225–232. https://doi.org/10.1097/ta.0000000000004278

Angiolillo, D. J., Cao, D., Sartori, S., Baber, U., Dangas, G., Zhang, Z., Vogel, B., Kunadian, V., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Ielasi, A., … Mehran, R. (2023). Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 16(20), 2514–2524. https://doi.org/10.1016/j.jcin.2023.08.019

Dehghani, P., Cao, D., Baber, U., Nicolas, J., Sartori, S., Pivato, C. A., Zhang, Z., Dangas, G., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., … Mehran, R. (2022). Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD. European Heart Journal - Cardiovascular Pharmacotherapy, 8(7), 707–716. https://doi.org/10.1093/ehjcvp/pvac016

Kunadian, V., Baber, U., Pivato, C. A., Cao, D., Dangas, G., Sartori, S., Zhang, Z., Angiolillo, D. J., Briguori, C., Cohen, D. J., Collier, T., Dudek, D., Gibson, M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Dehghani, P., … Mehran, R. (2022). Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index. JACC: Cardiovascular Interventions, 15(19), 1948–1960. https://doi.org/10.1016/j.jcin.2022.07.039

Mihatov, N., Secemsky, E. A., Kereiakes, D. J., Steg, P. G., Cutlip, D. E., Kirtane, A. J., Mehran, R., Zhao, B., Song, Y., Gibson, C. M., & Yeh, R. W. (2022). Individualizing Dual Antiplatelet Therapy (DAPT) Duration Based on Bleeding Risk, Ischemic Risk, or Both: An Analysis From the DAPT Study. Cardiovascular Revascularization Medicine, 41, 105–112. https://doi.org/10.1016/j.carrev.2022.01.006